Noncardiac surgery in patients on mechanical circulatory support

ASAIO Journal

Volumn 60, Issue 6, 2014, Pages 670-674

  Taghavi, Sharven ^a   Beyer, Carl ^a   Vora, Halley ^a   Jayarajan, Senthil N ^a   Toyoda, Yoshiya ^a   Dujon, Jay ^a   Sjoholm, Lars O ^a   Pathak, Abhijit ^a   Santora, Thomas A ^a   Goldberg, Amy J ^a   Rappold, Joseph F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extracorporeal membrane oxygenation; Left ventricular assist device; Mechanical circulatory support; Surgery

Indexed keywords

BLOOD; CARDIOVASCULAR SURGERY; LEFT VENTRICULAR ASSIST DEVICES;

ASSIST DEVICE; BLOOD PRODUCTS; BLOOD TRANSFUSION; CARDIAC SURGERY; MECHANICAL CIRCULATORY SUPPORT; MEDIAN SURVIVAL; RED BLOOD CELL; SURGICAL PROCEDURES;

HEART;

ACETYLSALICYLIC ACID; CREATININE; HYPERTENSIVE FACTOR; WARFARIN; ANTICOAGULANT AGENT;

ABDOMINAL SURGERY; ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; BLACK PERSON; BLOOD TRANSFUSION; CAUCASIAN; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; FEMALE; GENDER; GYNECOLOGIC SURGERY; HEMOSTASIS; HISPANIC; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; ORAL SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL PATIENT; SURVIVAL; SURVIVAL TIME; TRACHEOSTOMY; UROLOGICAL PROCEDURE; VASCULAR SURGERY; ADVERSE EFFECTS; AGED; BLOOD; HEART ASSIST DEVICE; HEART FAILURE; KAPLAN MEIER METHOD; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; BLOOD TRANSFUSION; CREATININE; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMOSTASIS, SURGICAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 84927697051     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000140     Document Type: Article

References (27)

1. Kirklin JK, Naftel DC, Kormos RL, et al: Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32: 141-156, 2013.
2. Favaloro RR, Bertolotti A, Diez M, et al: Adequate systemic perfusion maintained by a centrimag during acute heart failure. Texas Heart Inst J 35: 334, 2008.
3. Hoefer D, Ruttmann E, Poelzl G, et al: Outcome evaluation of the bridge to bridge concept in patients with cardiogenic shock. Ann Thorac Surg 82: 28-33, 2006.
4. Lietz K, Long JW, Kfoury AG, et al: Outcomes of left ventricular assist device implantation as destination therapy in the postrematch era implications for patient selection. Circulation 116:497-505, 2007.
5. Miller LW, Pagani FD, Russell SD, et al: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007.
6. Garatti A, Bruschi G, Colombo T, et al: Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. Am J Surg 197: 710-714, 2009.
7. McKellar SH, Morris DS, Mauermann WJ, Park SJ, Zietlow SP: Evolution of general surgical problems in patients with left ventricular assist devices. Surgery 152: 896-902, 2012.
8. Ahmed M, Le H, Aranda JM Jr, Klodell CT: Elective noncardiac surgery in patients with left ventricular assist devices. J Card Surg 27: 639-642, 2012.
9. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the heartmate ii left ventricular assist device as bridge-totransplant therapy. Ann Thorac Surg 86: 1227-1234, 2008.
10. John R, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A. Low thromboembolic risk for patients with the heartmate ii left ventricular assist device. J Thorac Cardiovasc Surg 136: 1318-1323, 2008.
11. Stehlik J, Nelson DM, Kfoury AG, et al: Outcome of noncardiac surgery in patients with ventricular assist devices. Am J Cardiol 103: 709-712, 2009.
12. Brown JB, Hallinan WM, Massey HT, et al: Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome? Surgery 146: 627-634, 2009.
13. Eckhauser AE, Melvin WV, Sharp KW: Management of general surgical problems in patients with left ventricular assist devices. Am Surg 72: 158-161, 2006.
14. Holman W, Rayburn B, McGiffin D, et al: Infection in ventricular assist devices: Prevention and treatment. Ann Thorac Surg 75:S48-S57, 2003.
15. Sharma V, Deo S, Stulak J, et al: Driveline infections in left ventricular assist devices: Implications for destination therapy. Ann Thorac Surg 94: 1381-1386, 2012.
16. Kitamura M, Hirota J, Niinami H, et al: Mechanical circulatory support for postcardiotomy ventricular failure: The Heart Institute of Japan experience 1984-1992. Artif Organs 17:897-900, 1993.
17. Smith C, Bellomo R, Raman JS, et al: An extracorporeal membrane oxygenation based approach to cardiogenic shock in an older population. Ann Thorac Surg 71: 1421-1427, 2001.
18. Zimpfer D, Heinisch B, Czerny M, et al: Late vascular complications after extracorporeal membrane oxygenation support. Ann Thorac Surg 81: 892-895, 2006.
19. Jayarajan SN, Taghavi S, Komaroff E, et al: Impact of extracorporeal membrane oxygenation or mechanical ventilation as bridge to combined heart-lung transplantation on short-term and long-term survival. Transplantation 97: 111-115, 2014.
20. Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA: Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg 96: 1259-1265, 2013.
21. Oliver WC: Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 13: 154-175, 2009.
22. Boyle AJ, Russell SD, Teuteberg JJ, et al: Low thromboembolism and pump thrombosis with the heartmate ii left ventricular assist device: Analysis of outpatient anti-coagulation. J Heart Lung Transplant 28: 881-887, 2009.
23. Morgan JA, Paone G, Nemeh HW, et al: Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant 31: 757-763, 2012.
24. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB: Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 208: 931-7, 937.e1, 2009.
25. Attisani M, Centofanti P, La Torre M, Campanella A, Sansone F, Rinaldi M: Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system. J Artif Organs 13: 202-206, 2010.
26. Meuris B, Arnout J, Vlasselaers D, Schetz M, Meyns B: Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: A possible alternative to oral anticoagulants. Artif Organs 31:402-405, 2007.
27. Schmid C, Wilhelm M, Dietl KH, Schmidt C, Hammel D, Scheld HH: Noncardiac surgery in patients with left ventricular assist devices. Surgery 129: 440-444, 2001.